Allogeneic stem cell transplantation for autoimmune diseases: nonmyeloablative conditioning regimens (Q35204121)

7 August 2017

1 reference

title

Allogeneic stem cell transplantation for autoimmune diseases: nonmyeloablative conditioning regimens (English)

1 reference

7 August 2017

Oyama Y

1

1 reference

7 August 2017

Traynor AE

series ordinal

2

1 reference

7 August 2017

Barr W

series ordinal

3

1 reference

7 August 2017

Burt RK

series ordinal

4

1 reference

7 August 2017

language of work or name

English

0 references

publication date

1 August 2003

1 reference

Bone Marrow Transplantation

7 August 2017

published in

1 reference

7 August 2017

volume

32 Suppl 1

1 reference

7 August 2017

page(s)

S81-3

1 reference

Effective treatment of autoimmune disease and progressive renal disease by mixed bone-marrow transplantation that establishes a stable mixed chimerism in BXSB recipient mice

7 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703950

Prevention of development of autoimmune disease in BXSB mice by mixed bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703950

Allogeneic hematolymphoid microchimerism and prevention of autoimmune disease in the rat. A relationship between allo- and autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703950

Inducing tolerance to MHC-matched allogeneic islet grafts in diabetic NOD mice by simultaneous islet and bone marrow transplantation under nonirradiative and nonmyeloablative conditioning therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703950

The mortality of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703950

Factors predicting a poor life prognosis in rheumatoid arthritis: an eight year prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703950

Survival with systemic sclerosis (scleroderma). A life-table analysis of clinical and demographic factors in 309 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703950

Prediction of survival in progressive systemic sclerosis by multivariate analysis of clinical features.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703950

In vivo CAMPATH-1H prevents GvHD following nonmyeloablative stem-cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703950

Induction of Donor-Specific Tolerance to Islet Allografts in Nonhuman Primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703950

Clinically demonstrable anti-autoimmunity mediated by allogeneic immune cells favorably affects outcome after stem cell transplantation in human autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703950

7 January 2021

Graft vs autoimmunity following allogeneic non-myeloablative blood stem cell transplantation in a patient with chronic myelogenous leukemia and severe systemic psoriasis and psoriatic polyarthritis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703950

7 January 2021

Cause of death in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703950

7 January 2021

Predictors of survival in systemic sclerosis (scleroderma)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703950

7 January 2021

Prediction of five-year survival following presentation with scleroderma: development of a simple model using three disease factors at first visit

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703950

7 January 2021

Identifiers

DOI

10.1038/SJ.BMT.1703950

1 reference

Dimensions Publication ID

7 August 2017

1000486678

0 references

1 reference